Pretreatment 18F-FDG PET/CT Radiomics Predict Local Recurrence in Patients Treated with Stereotactic Body Radiotherapy for Early-Stage Non–Small Cell Lung Cancer: A Multicentric Study-Reference-Cited by-同舟云学术

Pretreatment 18F-FDG PET/CT Radiomics Predict Local Recurrence in Patients Treated with Stereotactic Body Radiotherapy for Early-Stage Non–Small Cell Lung Cancer: A Multicentric Study

Published:2019-11-15 Issue:6 Volume:61 Page:814-820
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Dissaux Gurvan,Visvikis Dimitris,Da-ano Ronrick,Pradier Olivier,Chajon Enrique,Barillot Isabelle,Duvergé Loig,Masson Ingrid,Abgral Ronan,Santiago Ribeiro Maria-Joao,Devillers Anne,Pallardy Amandine,Fleury Vincent,Mahé Marc-André,De Crevoisier Renaud,Hatt Mathieu,Schick Ulrike

Publisher

Society of Nuclear Medicine

Subject

Radiology Nuclear Medicine and imaging

Reference29 articles.

1. Previous version: SEER cancer statistics review, 1975-2012. NIH website. https://seer.cancer.gov/csr/1975_2012/. Updated November 18, 2015. Accessed January 3, 2020.

2. Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer

3. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials

4. Stereotactic body radiotherapy for early-stage non-small-cell lung cancer: American Society of Clinical Oncology endorsement of the American Society for Radiation Oncology evidence-based guideline;Schneider;J Clin Oncol.,2018

5. Non–Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Future of Team-based Basic and Translational Science in Radiation Oncology;Seminars in Radiation Oncology;2024-10

2. Applying deep learning-based ensemble model to [18F]-FDG-PET-radiomic features for differentiating benign from malignant parotid gland diseases;Japanese Journal of Radiology;2024-09-10

3. Prediction of EGFR-TP53 genes co-mutations in patients with lung adenocarcinoma (LUAD) by 18F-FDG PET/CT radiomics;Clinical and Translational Oncology;2024-09-09

4. Prognostic nomogram combining 18F-FDG PET/CT radiomics and clinical data for stage III NSCLC survival prediction;Scientific Reports;2024-09-04

5. Integrating 18 F-FDG PET/CT Radiomics and Body Composition for Enhanced Prognostic Assessment in Patients with Esophageal Cancer;2024-09-03